Essa Pharma Inc (NASDAQ: EPIX) on Friday, soared 8.70% from the previous trading day, before settling in for the closing price of $1.61. Within the past 52 weeks, EPIX’s price has moved between $1.40 and $11.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 10.31%. With a float of $43.38 million, this company’s outstanding shares have now reached $44.39 million.
Let’s look at the performance matrix of the company that is accounted for 35 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Essa Pharma Inc (EPIX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Essa Pharma Inc is 2.22%, while institutional ownership is 98.86%. The most recent insider transaction that took place on Nov 01 ’24, was worth 12,018,409. In this transaction 10% Owner of this company sold 7,879,583 shares at a rate of $1.53, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 07 ’24, when Company’s Chief Operating Officer sold 694 for $6.03, making the entire transaction worth $4,185. This insider now owns 7,776 shares in total.
Essa Pharma Inc (EPIX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.31% per share during the next fiscal year.
Essa Pharma Inc (NASDAQ: EPIX) Trading Performance Indicators
Essa Pharma Inc (EPIX) is currently performing well based on its current performance indicators. A quick ratio of 38.64 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Essa Pharma Inc (EPIX)
Essa Pharma Inc (NASDAQ: EPIX) saw its 5-day average volume 0.42 million, a positive change from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 46.21%. Additionally, its Average True Range was 0.11.
During the past 100 days, Essa Pharma Inc’s (EPIX) raw stochastic average was set at 5.40%, which indicates a significant decrease from 71.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.08% in the past 14 days, which was lower than the 218.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.5676, while its 200-day Moving Average is $5.2549. Nevertheless, the first resistance level for the watch stands at $1.8484 in the near term. At $1.9468, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0735. If the price goes on to break the first support level at $1.6233, it is likely to go to the next support level at $1.4966. The third support level lies at $1.3982 if the price breaches the second support level.
Essa Pharma Inc (NASDAQ: EPIX) Key Stats
Market capitalization of the company is 84.43 million based on 44,389K outstanding shares. Right now, sales total 0 K and income totals -28,540 K. The company made 0 K in profit during its latest quarter, and -6,360 K in sales during its previous quarter.
